10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
The combination of diagnostics and imaging in infectious diseases offers a comprehensive approach to understanding and managing infections. Diagnostics, including microbiological tests and molecular assays, allow for the precise identification of causative agents, facilitating targeted treatments. Meanwhile, imaging techniques provide critical insight into the severity and extent of infection-related damage to organs or tissues. In infectious diseases diagnostics and imaging, advances such as positron emission tomography (PET) and magnetic resonance imaging (MRI) are increasingly being used to assess inflammation and infection in real-time, enabling personalized treatment plans. This integrated approach enhances both the detection of infections and the monitoring of treatment progress, ultimately leading to better clinical outcomes.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria